Buchumschlag

DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

Current clinical guidelines suggest that breast cancers with low hormone receptor expression (LowHR) in 1-10% of tumor cells should be regarded as hormone receptor positive. However, clinical data show that these patients have worse outcome compared to patients with hormone receptor expression above...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jurmeister, Philipp (VerfasserIn) , Weber, Karsten (VerfasserIn) , Villegas, Sonia (VerfasserIn) , Karn, Thomas (VerfasserIn) , Untch, Michael (VerfasserIn) , Thieme, Anne (VerfasserIn) , Müller, Volkmar (VerfasserIn) , Taube, Eliane (VerfasserIn) , Fasching, Peter (VerfasserIn) , Schmitt, Wolfgang D. (VerfasserIn) , Marmé, Frederik (VerfasserIn) , Stickeler, Elmar (VerfasserIn) , Sinn, Bruno V. (VerfasserIn) , Jank, Paul (VerfasserIn) , Schem, Christian (VerfasserIn) , Klauschen, Frederick (VerfasserIn) , Mackelenbergh, Marion Tina van (VerfasserIn) , Denkert, Carsten (VerfasserIn) , Loibl, Sibylle (VerfasserIn) , Capper, David (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 03 October 2021
In: Clinical epigenetics
Year: 2021, Jahrgang: 13, Pages: 1-10
ISSN:1868-7083
DOI:10.1186/s13148-021-01176-5
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13148-021-01176-5
Volltext
Verfasserangaben:Philipp Jurmeister, Karsten Weber, Sonia Villegas, Thomas Karn, Michael Untch, Anne Thieme, Volkmar Müller, Eliane Taube, Peter Fasching, Wolfgang D. Schmitt, Frederik Marmé, Elmar Stickeler, Bruno V. Sinn, Paul Jank, Christian Schem, Frederick Klauschen, Marion van Mackelenbergh, Carsten Denkert, Sibylle Loibl and David Capper
Beschreibung
Zusammenfassung:Current clinical guidelines suggest that breast cancers with low hormone receptor expression (LowHR) in 1-10% of tumor cells should be regarded as hormone receptor positive. However, clinical data show that these patients have worse outcome compared to patients with hormone receptor expression above 10%. We performed DNA methylation profiling on 23 LowHR breast cancer specimens, including 13 samples with HER2 amplification and compared our results with a reference breast cancer cohort from The Cancer Genome Atlas to clarify the status for this infrequent but important patient subgroup.
Beschreibung:Gesehen am 09.12.2021
Beschreibung:Online Resource
ISSN:1868-7083
DOI:10.1186/s13148-021-01176-5

Ähnliche Einträge